Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis

202043 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT01633112.

Good health and well-being

Published in: JAMA Neurology

Volume 78, Issue 1, pp. 48-48

Field-Weighted Citation Impact: 3.62